STAT3 and breast carcinoma: Coculture of breast cancer cells with tumor tissue-derived MSCs (BC-MSCs) led to the development of cisplatin resistance; this process could be associated with the IL-6 secreted by BC-MSCs, which activates STAT3 signaling in breast cancer cells and promotes cell survival [42].